Sage Journals: Discover world-class research

Open access

Research article

First published 2024-10

Autoimmune encephalitis following treatment with durvalumab for small-cell lung cancer

Yu-Lan Qian, Ye Jiang, Yin-Hua Gong [...]

Journal of International Medical Research

Open access

Review article

First published 2019

Durvalumab for stage III non-small-cell lung cancer patients: clinical evidence and real-world experience

Angela Botticella, Laura Mezquita, Cecile Le Pechoux [...]

Therapeutic Advances in Respiratory Disease

Open access

Research article

First published 2025

Cost-effectiveness of perioperative durvalumab plus neoadjuvant chemotherapy for muscle invasive bladder cancer in the United States

Caicong You, Jiahao Zhang, Jianying Lei [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2022

Prospective analysis of factors precluding the initiation of durvalumab from an interim analysis of a phase II trial of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable,locally advanced non-small cell lung cancer in Japan (SAMURAI study)

Shigeru Tanzawa, Tomonori Makiguchi, Sadatomo Tasaka [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2025

TROPION-Breast04: a randomized phase III study of neoadjuvant datopotamab deruxtecan (Dato-DXd) plus durvalumab followed by adjuvant durvalumab versus standard of care in patients with treatment-naïve early-stage triple negative or HR-low/HER2− breast cancer

Heather L. McArthur, Sara M. Tolaney, Rebecca Dent [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2025

Tremelimumab Plus Durvalumab in Advanced Hepatocellular Carcinoma Treatment: A Pharmacovigilance Comparative Analysis Between Eudravigilance and HIMALAYA Study

Eleonora Castellana, Patricia Madalina Budau, Maria Rachele Chiappetta

Hospital Pharmacy

Retricted access

Research article

First published 2022-2

Cost-effectiveness analysis of durvalumab plus etoposide: platinum in the first-line therapy of extensive stage small-cell lung cancer from the Chinese payers’ perspective

Ying-hui Tong, Hai-ying Ding, Wen-xiu Xin [...]

Tumori Journal

Open access

Research article

First published 2021

A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable,locally advanced non-small-cell lung cancer in Japan (SAMURAI study)

Shigeru Tanzawa, Sunao Ushijima, Kazuhiko Shibata [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2026

Sequential or upfront triple combination with durvalumab,tremelimumab,and bevacizumab for patients with unresectable hepatocellular carcinoma: the MONTBLANC trial protocol (AIO-HEP-0325/ass)

Najib Ben Khaled, Ursula Ehmer, Ilja Kubisch [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2022

Pilot Study of Combination Gemogenovatucel-T (Vigil) and Durvalumab in Women With Relapsed BRCA-wt Triple-Negative Breast or Ovarian Cancer

Minal Barve, Phylicia Aaron, Luisa Manning [...]

Clinical Medicine Insights: Oncology

Search results